Exact Therapeutics AS (OSL:EXTX) Price-to-Tangible-Book : 5.12 (As of May. 25, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Exact Therapeutics AS Price-to-Tangible-Book?

As of today (2024-05-25), Exact Therapeutics AS's share price is kr7.20. Exact Therapeutics AS's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was kr1.41. Hence, Exact Therapeutics AS's Price to Tangible Book Ratio of today is 5.12.

The historical rank and industry rank for Exact Therapeutics AS's Price-to-Tangible-Book or its related term are showing as below:

OSL:EXTX' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 4.93 Med: 5.54 Max: 8.53
Current: 5.11

During the past 7 years, Exact Therapeutics AS's highest Price to Tangible Book Ratio was 8.53. The lowest was 4.93. And the median was 5.54.

OSL:EXTX's Price-to-Tangible-Book is ranked worse than
72.53% of 1223 companies
in the Biotechnology industry
Industry Median: 2.78 vs OSL:EXTX: 5.11

A closely related ratio is called PB Ratio. As of today, Exact Therapeutics AS's share price is kr7.20. Exact Therapeutics AS's Book Value per Sharefor the quarter that ended in Dec. 2023 was kr1.41. Hence, Exact Therapeutics AS's P/B Ratio of today is 5.12.

Exact Therapeutics AS Price-to-Tangible-Book Historical Data

The historical data trend for Exact Therapeutics AS's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Exact Therapeutics AS Price-to-Tangible-Book Chart

Exact Therapeutics AS Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Get a 7-Day Free Trial

5.54

4.93

5.53

8.53

Exact Therapeutics AS Semi-Annual Data
	Dec17	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial						4.93	7.32	5.53	8.00	8.53

Competitive Comparison of Exact Therapeutics AS's Price-to-Tangible-Book

For the Biotechnology subindustry, Exact Therapeutics AS's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Exact Therapeutics AS's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Exact Therapeutics AS's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Exact Therapeutics AS's Price-to-Tangible-Book falls into.

Exact Therapeutics AS Price-to-Tangible-Book Calculation

Exact Therapeutics AS's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	7.20	/	1.406
	=	5.12

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Exact Therapeutics AS Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Exact Therapeutics AS's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Exact Therapeutics AS (OSL:EXTX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Exact Therapeutics AS (OSL:EXTX) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

N/A

Address

Ostre Aker vei 19, Oslo, NOR, 0581

Website

https://www.exact-tx.com

Exact Therapeutics AS is a clinical-stage biotechnology company. It is developing a technology platform for therapeutic enhancement - Acoustic Cluster Therapy (ACT). ACT sonoporation is an approach to ultrasound-mediated, targeted drug enhancement that will amplify the clinical utility of therapeutic agents across a multitude of indications including within oncology (chemotherapy, immunotherapy), infectious diseases, and neurological conditions.

Exact Therapeutics AS (OSL:EXTX) Headlines

No Headlines